Skip to content

4528.T

ONO PHARMACEUTICAL CO.,LTD.

プライム · 医薬品 · 医薬品 · JP

JPY 2,224.50
−9.99%
Ask drillr

Year over year

Reported trailing growth

Revenue
+4.5%
EBITDA
—
EBIT
-10.2%
EPS
-15.3%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
-3.8%
EBITDA
—
EPS
+7.4%

Three-year CAGR

Revenue
+10.4%
EBITDA
-10.5%
EBIT
-16.7%
Net income
-14.7%
EPS
-13.1%
Free cash flow
+11.0%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026